123 related articles for article (PubMed ID: 37669910)
1. Effects of Sport Stacking on Cognition in Patients With Mild Alzheimer's Disease and MCI: Preliminary Findings of Randomized Controlled Trial.
Yang Z; Yang J; Yu DSF; Liu D; Ding F
J Geriatr Psychiatry Neurol; 2024 Jan; 37(1):24-38. PubMed ID: 37669910
[TBL] [Abstract][Full Text] [Related]
2. Effects of Sport Stacking on Neuropsychological, Neurobiological, and Brain Function Performances in Patients With Mild Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Controlled Trial.
Yang Z; Zhang W; Liu D; Zhang SS; Tang Y; Song J; Long J; Yang J; Jiang H; Li Y; Liu X; Lü Y; Ding F
Front Aging Neurosci; 2022; 14():910261. PubMed ID: 35645781
[TBL] [Abstract][Full Text] [Related]
3. Psychometric properties of the Alzheimer's Disease Cooperative Study - Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial.
Potashman M; Pang M; Tahir M; Shahraz S; Dichter S; Perneczky R; Nolte S
BMC Geriatr; 2023 Mar; 23(1):124. PubMed ID: 36879199
[TBL] [Abstract][Full Text] [Related]
4. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
5. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
[TBL] [Abstract][Full Text] [Related]
6. Short-term delayed recall of auditory verbal learning test provides equivalent value to long-term delayed recall in predicting MCI clinical outcomes: A longitudinal follow-up study.
Xu Y; Chen K; Zhao Q; Li F; Guo Q
Appl Neuropsychol Adult; 2020; 27(1):73-81. PubMed ID: 30470140
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
[TBL] [Abstract][Full Text] [Related]
8. Factors contributing to cognitive improvement effects of acupuncture in patients with mild cognitive impairment: a pilot randomized controlled trial.
Kim JH; Cho MR; Shin JC; Park GC; Lee JS
Trials; 2021 May; 22(1):341. PubMed ID: 33980288
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Brain-Derived Neurotrophic Factor and Cognitive Decline in Patients with Mild Cognitive Impairment and Dementia.
Nikolac Perkovic M; Borovecki F; Filipcic I; Vuic B; Milos T; Nedic Erjavec G; Konjevod M; Tudor L; Mimica N; Uzun S; Kozumplik O; Svob Strac D; Pivac N
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979505
[TBL] [Abstract][Full Text] [Related]
10. Protecting cognition from aging and Alzheimer's disease: a computerized cognitive training combined with reminiscence therapy.
Barban F; Annicchiarico R; Pantelopoulos S; Federici A; Perri R; Fadda L; Carlesimo GA; Ricci C; Giuli S; Scalici F; Turchetta CS; Adriano F; Lombardi MG; Zaccarelli C; Cirillo G; Passuti S; Mattarelli P; Lymperopoulou O; Sakka P; Ntanasi E; Moliner R; Garcia-Palacios A; Caltagirone C
Int J Geriatr Psychiatry; 2016 Apr; 31(4):340-8. PubMed ID: 26205305
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.
Frölich L; Wunderlich G; Thamer C; Roehrle M; Garcia M; Dubois B
Alzheimers Res Ther; 2019 Feb; 11(1):18. PubMed ID: 30755255
[TBL] [Abstract][Full Text] [Related]
12. Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.
Peng GP; Feng Z; He FP; Chen ZQ; Liu XY; Liu P; Luo BY
CNS Neurosci Ther; 2015 Jan; 21(1):15-22. PubMed ID: 25146658
[TBL] [Abstract][Full Text] [Related]
13. Galantamine for Alzheimer's disease and mild cognitive impairment.
Loy C; Schneider L
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD001747. PubMed ID: 16437436
[TBL] [Abstract][Full Text] [Related]
14. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
[TBL] [Abstract][Full Text] [Related]
15. Differences between episodic and semantic memory in predicting observation-based activities of daily living in mild cognitive impairment and Alzheimer's disease.
Nakhla MZ; Banuelos D; Pagán C; Gavarrete Olvera A; Razani J
Appl Neuropsychol Adult; 2022; 29(6):1499-1510. PubMed ID: 33689539
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
[TBL] [Abstract][Full Text] [Related]
17. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
[TBL] [Abstract][Full Text] [Related]
18. False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease.
Loring DW; Goldstein FC; Chen C; Drane DL; Lah JJ; Zhao L; Larrabee GJ;
Arch Clin Neuropsychol; 2016 Jun; 31(4):313-31. PubMed ID: 27084732
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC
Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
